| Nasdaq: ICAD
iCAD, Inc. is a provider of advanced image analysis and workflow solutions for the early identification of cancer. Its industry leading solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection systems and workflow solutions for mammography and computed radiography, Magnetic Resonance Imaging, and Computed Tomography. It also offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The company was founded in 1984 and is headquartered in Nashua, NH.